PUB - Publikationen an der Universität Bielefeld

[Demographic change and disease rates: a projection until 2050].
Peters E, Pritzkuleit R, Beske F, Katalinic A., Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 53(5), 2010
PMID: 20376420

Health and health-care systems in southeast Asia: diversity and transitions.
Chongsuvivatwong V, Phua KH, Yap MT, Pocock NS, Hashim JH, Chhem R, Wilopo SA, Lopez AD., Lancet 377(9763), 2011
PMID: 21269685

Estimating measles transmission potential in Italy over the period 2010-2011.
Ajelli M, Merler S, Fumanelli L, Bella A, Rizzo C., Ann. Ist. Super. Sanita 50(4), 2014
PMID: 25522076

The impact of demographic changes on the epidemiology of herpes zoster: Spain as a case study.
Marziano V, Poletti P, Guzzetta G, Ajelli M, Manfredi P, Merler S., Proc. Biol. Sci. 282(1804), 2015
PMID: 25761709

Realistic population dynamics in epidemiological models: the impact of population decline on the dynamics of childhood infectious diseases. Measles in Italy as an example.
Manfredi P, Williams JR., Math Biosci 192(2), 2004
PMID: 15627491

Ageing populations and childhood infections: the potential impact on epidemic patterns and morbidity.
Williams JR, Manfredi P., Int J Epidemiol 33(3), 2004
PMID: 15044415

Herpes zoster in Germany: quantifying the burden of disease.
Ultsch B, Siedler A, Rieck T, Reinhold T, Krause G, Wichmann O., BMC Infect. Dis. 11(), 2011
PMID: 21679419

Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox.
Brisson M, Gay NJ, Edmunds WJ, Andrews NJ., Vaccine 20(19-20), 2002
PMID: 12057605

Herpes Zoster Risk Reduction through Exposure to Chickenpox Patients: A Systematic Multidisciplinary Review.
Ogunjimi B, Van Damme P, Beutels P., PLoS ONE 8(6), 2013
PMID: 23805224

Modelling the impact of immunization on the epidemiology of varicella zoster virus.
Brisson M, Edmunds WJ, Gay NJ, Law B, De Serres G., Epidemiol. Infect. 125(3), 2000
PMID: 11218215

Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England.
van Hoek AJ, Melegaro A, Zagheni E, Edmunds WJ, Gay N., Vaccine 29(13), 2011
PMID: 21277405

Modelling the impact of varicella vaccination on varicella and zoster.
Karhunen M, Leino T, Salo H, Davidkin I, Kilpi T, Auranen K., Epidemiol. Infect. 138(4), 2009
PMID: 19796447

Hope-Simpson's progressive immunity hypothesis as a possible explanation for herpes zoster incidence data.
Guzzetta G, Poletti P, Del Fava E, Ajelli M, Scalia Tomba GP, Merler S, Manfredi P., Am. J. Epidemiol. 177(10), 2013
PMID: 23548754

Estimating the age-specific duration of herpes zoster vaccine protection: a matter of model choice?
Bilcke J, Ogunjimi B, Hulstaert F, Van Damme P, Hens N, Beutels P., Vaccine 30(17), 2011
PMID: 21964056

Review of the Persistence of Herpes Zoster Vaccine Efficacy in Clinical Trials.
Cook SJ, Flaherty DK., Clin Ther 37(11), 2015
PMID: 26602282

Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults.
Lal H, Cunningham AL, Godeaux O, Chlibek R, Diez-Domingo J, Hwang SJ, Levin MJ, McElhaney JE, Poder A, Puig-Barbera J, Vesikari T, Watanabe D, Weckx L, Zahaf T, Heineman TC; ZOE-50 Study Group, Arya M, Athan E, Cunningham AL, De Looze F, Seale JP, Yeo W, Goldani L, Jacob W, Luiz Neto J, dos Santos RR, Weckx L, Zerbini C, Dutz J, Ghesquiere W, Gorfinkel I, McElhaney JE, McNeil S, Powell C, Chlibek R, Smetana J, Poder A, Ahonen A, Korhonen T, Seppa I, Vesikari T, Arnou R, Beytout J, Saillard D, Dominicus R, Esen M, Plaßmann G, Schwarz T, Tyler K, Hui D, Leung E, Pellegrino A, Volpi A, Endo M, Watanabe D, Cheong HJ, Choi WS, Choo EJ, Kim YK, Lee JS, Park DW, Peck KR, Song YG, Barba-Gomez JF, de Los Santos AM, Tinoco JC, Bayas JM, Caso C, Roure JL, Via LM, Perez SN, Lopez CN, Puig-Barbera J, de la Pinta ML, Riera MT, Diez-Domingo J, Bengner M, Berglund J, Blom KB, Liu B, Pauksens K, Rombo L, Chen MF, Cheng HS, Hwang SJ, Liu CS, McNally D, Thompson A, Andrews C, Collins H, Downey H, Ervin J, Freedman M, Hoekstra J, Hull S, Levin M, Marcadis I, Rankin B, Van Cleeff M., N. Engl. J. Med. 372(22), 2015
PMID: 25916341

Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older.
Cunningham AL, Lal H, Kovac M, Chlibek R, Hwang SJ, Diez-Domingo J, Godeaux O, Levin MJ, McElhaney JE, Puig-Barbera J, Vanden Abeele C, Vesikari T, Watanabe D, Zahaf T, Ahonen A, Athan E, Barba-Gomez JF, Campora L, de Looze F, Downey HJ, Ghesquiere W, Gorfinkel I, Korhonen T, Leung E, McNeil SA, Oostvogels L, Rombo L, Smetana J, Weckx L, Yeo W, Heineman TC; ZOE-70 Study Group, Athan E, Cunningham AL, de Looze F, Eizenberg P, Yeo W, Avelino-Silva TJ, Neto JL, Santos RR, Weckx L, Zerbini CA, Gauthier JS, Ghesquiere W, Gorfinkel I, McElhaney JE, McNeil SA, Toma A, Chlibek R, Smetana J, Poder A, Ahonen A, Forsten A, Karppa T, Korhonen T, Seppa I, Vesikari T, Esen M, Schwarz TF, Leung E, Desole MG, Icardi G, Pellegrino A, Staniscia T, Volpi A, Ikematsu H, Watanabe D, Choi WS, Barba-Gomez JF, Mascarenas de Los Santos A, Tinoco JC, Brotons C, Caso C, Diez-Domingo J, Narejos Perez S, Puig-Barbera J, Rodriguez de la Pinta ML, Berglund J, Blom KB, Liu B, Pauksens K, Rombo L, Hwang SJ, Thompson A, Andrews C, Jackson Downey H, Freedman M, Levin M, Arbi MB, Campora L, Catteau G, Curran D, Godeaux O, Heineman TC, Kovac M, Lal H, Marion S, Oostvogels L, Oujaa M, Ravault S, Abeele CV, Vastiau I, Zahaf T, Godeaux O, Heineman TC, Lal H, Zahaf T, Ahonen A, Andrews C, Athan E, Junqueira T, Barba-Gomez JF, Berglund J, Berndtsson Blom K, Brotons C, Caso C, Chlibek R, Choi WS, Cunningham AL, de Looze F, Diez-Domingo J, Downey H, Eizenberg P, Esen M, Forsten A, Freedman M, Gauthier JS, Ghesquiere W, Desole MG, Hwang SJ, Icardi G, Ikematsu H, Karppa T, Korhonen T, Liu B, Mascarenas de Los Santos A, McElhaney JE, McNeil SA, Narejos Perez S, Leung E, Neto JL, Pauksens K, Pellegrino A, Poder A, Puig-Barbera J, Santos RR, Rodriguez ML, Rombo L, Schwarz TF, Seppa I, Smetana J, Staniscia T, Thompson A, Tinoco JC, Toma A, Vesikari T, Volpi A, Weckx L, Yeo W, Zerbini C, Arbi MB, Catteau G, Curran D, Marion S, Oujaa M, Abeele CV, Zahaf T, Ahonen A, Athan E, Barba-Gomez JF, Campora L, Chlibek R, Cunningham AL, de Looze F, Diez-Domingo J, Jackson Downey H, Ghesquiere W, Godeaux O, Gorfinkel I, Heineman T, Hwang SJ, Korhonen T, Kovac M, Lal H, Leung E, Levin MJ, McElhaney JE, McNeil SA, Oostvogels L, Puig J, Ravault S, Rombo L, Smetana J, Abeele CV, Vastiau I, Vesikari T, Watanabe D, Weckx L, Yeo W, Zahaf T, Chlibek R, Cunningham AL, Diez-Domingo J, Heineman T, Hwang SJ, Kovac M, Lal H, Levin MJ, McElhaney JE, Oostvogels L, Puig-Barbera J, Heineman TC., N. Engl. J. Med. 375(11), 2016
PMID: 27626517

Current and future effects of varicella and herpes zoster vaccination in Germany - Insights from a mathematical model in a country with universal varicella vaccination.
Horn J, Karch A, Damm O, Kretzschmar ME, Siedler A, Ultsch B, Weidemann F, Wichmann O, Hengel H, Greiner W, Mikolajczyk RT., Hum Vaccin Immunother 12(7), 2016
PMID: 26835890

Social contacts and mixing patterns relevant to the spread of infectious diseases.
Mossong J, Hens N, Jit M, Beutels P, Auranen K, Mikolajczyk R, Massari M, Salmaso S, Tomba GS, Wallinga J, Heijne J, Sadkowska-Todys M, Rosinska M, Edmunds WJ., PLoS Med. 5(3), 2008
PMID: 18366252

A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, Arbeit RD, Simberkoff MS, Gershon AA, Davis LE, Weinberg A, Boardman KD, Williams HM, Zhang JH, Peduzzi PN, Beisel CE, Morrison VA, Guatelli JC, Brooks PA, Kauffman CA, Pachucki CT, Neuzil KM, Betts RF, Wright PF, Griffin MR, Brunell P, Soto NE, Marques AR, Keay SK, Goodman RP, Cotton DJ, Gnann JW Jr, Loutit J, Holodniy M, Keitel WA, Crawford GE, Yeh SS, Lobo Z, Toney JF, Greenberg RN, Keller PM, Harbecke R, Hayward AR, Irwin MR, Kyriakides TC, Chan CY, Chan IS, Wang WW, Annunziato PW, Silber JL; Shingles Prevention Study Group., N. Engl. J. Med. 352(22), 2005
PMID: 15930418

Vaccination against Herpes Zoster and Postherpetic Neuralgia.
Oxman MN, Levin MJ; Shingles Prevention Study Group, Oxman MN, Arbeit RD, Barry P, Beisel C, Boardman KD, Colling CL, Davis LE, Gelb LD, Gershon AA, Hayward AR, Irwin MR, Johnson GR, Levin MJ, Peduzzi PN, Schmader KE, Simberkoff MS, Straus SE, Weinberg A, Williams HM, Annunziato P, Chan CY, Chan IS, Silber JL., J. Infect. Dis. 197 Suppl 2(), 2008
PMID: 18419402

Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years.
Schmader KE, Levin MJ, Gnann JW Jr, McNeil SA, Vesikari T, Betts RF, Keay S, Stek JE, Bundick ND, Su SC, Zhao Y, Li X, Chan IS, Annunziato PW, Parrino J., Clin. Infect. Dis. 54(7), 2012
PMID: 22291101

Baillot A, Toikkanen S, Monazahian M., 2016

Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community.
Ultsch B, Damm O, Beutels P, Bilcke J, Bruggenjurgen B, Gerber-Grote A, Greiner W, Hanquet G, Hutubessy R, Jit M, Knol M, von Kries R, Kuhlmann A, Levy-Bruhl D, Perleth M, Postma M, Salo H, Siebert U, Wasem J, Wichmann O., Pharmacoeconomics 34(3), 2016
PMID: 26477039